Cargando…
Frenemies in the Microenvironment: Harnessing Mast Cells for Cancer Immunotherapy
Tumor development, progression, and resistance to therapies are influenced by the interactions between tumor cells and the surrounding microenvironment, comprising fibroblasts, immune cells, and extracellular matrix proteins. In this context, mast cells (MCs) have recently emerged as important playe...
Autores principales: | Sulsenti, Roberta, Jachetti, Elena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10303176/ https://www.ncbi.nlm.nih.gov/pubmed/37376140 http://dx.doi.org/10.3390/pharmaceutics15061692 |
Ejemplares similares
-
Interleukin-32: Frenemy in cancer?
por: Han, Sora, et al.
Publicado: (2019) -
Evolution of Bacterial “Frenemies”
por: Darch, Sophie E., et al.
Publicado: (2017) -
Repurposing of the Antiepileptic Drug Levetiracetam to Restrain Neuroendocrine Prostate Cancer and Inhibit Mast Cell Support to Adenocarcinoma
por: Sulsenti, Roberta, et al.
Publicado: (2021) -
Man and Microbe: Fraternizing with the frenemy
por: Subramanian, Shankar
Publicado: (2019) -
Harnessing the Power of Mast Cells in unconventional Immunotherapy Strategies and Vaccine Adjuvants
por: Willows, Steven, et al.
Publicado: (2020)